Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.